晚期交界性卵巢肿瘤患者行保留生育功能手术:单中心队列的肿瘤学结局
INTRODUCTION: The purpose of this single-center retrospective analysis is to evaluate the long-term feasibility and oncologic safety of fertility-sparing surgery (FSS) in patients with advanced borderline ovarian tumors (BOTs).…
要点
- 中位无复发生存期148个月,首次复发多为孤立卵巢复发(69.7%)。
- 单因素分析中卵巢受累侧别(p=0.027)和附件手术类型(p=0.019)是复发的显著预测因素。
核心结论
- 尽管复发率高,本系列显示保留生育功能手术在晚期交界性卵巢肿瘤管理中具有极好的肿瘤学结局。
- 作者建议对尚未完成生育愿望的年轻晚期交界性卵巢肿瘤女性保留生育功能。
研究设计与样本
- 单中心回顾性分析,评估1985年至2021年接受保留生育功能手术的FIGO IIA-IIIC期交界性卵巢肿瘤患者的长期可行性和肿瘤学安全性。
- 共纳入86例患者,大多数为浆液性组织学(90.7%)、双侧卵巢受累(61.6%)、III期疾病(54.6%)伴非浸润性植入物(80.2%)。
主要发现
- 最常见的手术方式为单侧附件切除伴或不伴对侧囊肿切除(58.1%)。
- 多数患者首次(69.7%)和第二次(60.0%)复发为孤立卵巢复发;这些患者中多数再次接受保留生育功能手术,而第三次复发时更倾向根治性手术(53.3%)。
- 3例复发患者发展为浸润性低级别浆液性卵巢癌。
- 单因素分析中,卵巢受累侧别(p=0.027)和附件手术类型(p=0.019)是复发的显著预测因素。
临床怎么用
- 作者建议对尚未完成生育愿望的年轻晚期交界性卵巢肿瘤女性保留生育功能。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The purpose of this single-center retrospective analysis is to evaluate the long-term feasibility and oncologic safety of fertility-sparing surgery (FSS) in patients with advanced borderline ovarian tumors (BOTs). METHODS: Patients with FIGO stage IIA-IIIC BOTs treated with FSS between 1985 and 2021 were evaluated. RESULTS: A total of 86 patients were included, the majority having serous histology (90.7 %), bilateral ovarian involvement (61.6 %), and stage III disease (54.6 %) with non-invasive implants (80.2 %). The most common surgical approach was unilateral adnexectomy with/without contralateral cystectomy (58.1 %) After a median follow-up of 182 months, 66 patients (76,7 %) experienced recurrence, with a median RFS of 148 months; among them, 36 relapsed more than once. Most patients experienced isolated ovarian recurrence at both first (69.7 %) and second relapse (60.0 %); in these patients, a rechallenge with FSS was offered in most cases, whereas radical surgery was preferred (53.3 %) at third recurrence. Three patients with recurrent disease developed invasive low-grade serous ovarian carcinoma (LGSOC). At univariable analysis, the laterality of ovarian involvement (p = 0.027) and the type of adnexal procedure (p = 0.019) were significant predictors of recurrence. At last follow-up 83 patients (96.5 %) were alive without evidence of disease, 2 patients (2.3 %) were alive with persistent/recurrent disease and death occurred in only one patient (1.2 %). CONCLUSIONS: Despite the high recurrence rate, our series demonstrates that FSS has excellent oncologic outcomes in managing advanced BOTs. Therefore, fertility preservation is advised in young women with advanced BOTs who have not yet fulfilled their desire for childbearing.
引用
- Bianchi T, Grassi T, De Ponti E, et al. Fertility sparing surgery in patients with advanced borderline ovarian tumors: Oncologic outcomes of a single-institution cohort. Gynecol Oncol. 2025. PMID: 40516203. doi:10.1016/j.ygyno.2025.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。